[go: up one dir, main page]

AU2001253029A1 - T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer - Google Patents

T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer

Info

Publication number
AU2001253029A1
AU2001253029A1 AU2001253029A AU5302901A AU2001253029A1 AU 2001253029 A1 AU2001253029 A1 AU 2001253029A1 AU 2001253029 A AU2001253029 A AU 2001253029A AU 5302901 A AU5302901 A AU 5302901A AU 2001253029 A1 AU2001253029 A1 AU 2001253029A1
Authority
AU
Australia
Prior art keywords
mage
inducing
vectors
cancer
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001253029A
Inventor
Maria Bettinotti
Francesco Marincola
Monica Panelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2001253029A1 publication Critical patent/AU2001253029A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001253029A 2000-03-30 2001-03-29 T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer Abandoned AU2001253029A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19320600P 2000-03-30 2000-03-30
US60193206 2000-03-30
PCT/US2001/010312 WO2001074847A2 (en) 2000-03-30 2001-03-29 T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer

Publications (1)

Publication Number Publication Date
AU2001253029A1 true AU2001253029A1 (en) 2001-10-15

Family

ID=22712651

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001253029A Abandoned AU2001253029A1 (en) 2000-03-30 2001-03-29 T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer

Country Status (2)

Country Link
AU (1) AU2001253029A1 (en)
WO (1) WO2001074847A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3392270T (en) 2011-09-15 2020-11-24 Us Health T cell receptors recognizing hla-a1- or hla-cw7-restricted mage
AU2018274216A1 (en) 2017-05-24 2019-12-12 Novartis Ag Antibody-cytokine engrafted proteins and methods of use in the treatment of cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060257A (en) * 1994-06-03 2000-05-09 Ludwig Institute For Cancer Research Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
EP1064022A4 (en) * 1998-03-13 2004-09-29 Epimmune Inc Hla-binding peptides and their uses
CA2332786A1 (en) * 1998-05-29 1999-12-02 Epimmune Inc. Identification of broadly reactive dr restricted epitopes
IT1309584B1 (en) * 1999-02-26 2002-01-24 San Raffaele Centro Fond IMMUNOGENIC PEPTIDES DERIVED FROM MAGE-3 PRESENTED BY MHC OF CLASS II AND THEIR USE.
AU5898400A (en) * 1999-06-29 2001-01-31 Epimmune, Inc. Hla binding peptides and their uses
CA2386088A1 (en) * 1999-10-19 2001-04-26 Ludwig Institute For Cancer Research Mage-a12 antigenic peptides and uses thereof

Also Published As

Publication number Publication date
WO2001074847A3 (en) 2002-03-21
WO2001074847A2 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
AU3760100A (en) Immunostimulatory nucleic acids and antigens
AU2605501A (en) Inducing cellular immune responses to prostate cancer antigens using peptide andnucleic acid compositions
AU2087401A (en) Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions
WO1999058658A3 (en) Expression vectors for stimulating an immune response and methods of using the same
IL162077A (en) Combination of dna plasmid vector and an immune modulatory sequence and use thereof
WO1999066879A3 (en) Systemic immune activation method using nucleic acid-lipid complexes
WO2001034801A3 (en) Recombinant gelatin in vaccines
AU2001249380A1 (en) Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
IL174544A0 (en) Vaccine compositions comprising an interleukin 18 and saponin adjuvant system
AU2002252731A1 (en) Compositions and methods of double-targeting virus infections and cancer cells
AU2872202A (en) Expression vectors able to elicit improved immune response and methods of using same
AU2273701A (en) Hla class i a2 tumor associated antigen peptides and vaccine compositions
AU2001241918A1 (en) Methods of enhancing activity of vaccines and vaccine compositions
AU2002249852A1 (en) Enhancement of immune response to vaccine by interferon alpha
AU2002219988A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2002330053A1 (en) Chemokines as adjuvants of immune response
AU2003304145A1 (en) Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia
AU2085001A (en) Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositions
AU2001253029A1 (en) T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer
AU2001297741A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2088701A (en) Inducing cellular immune responses to p53 using peptide and nucleic acid compositions
AU2002217991A1 (en) Compositions and methods relating to prostate specific genes and proteins
AU2002259005A1 (en) Compositions and methods for inducing cancer cell death
AU2002236579A1 (en) Compositions and methods relating to prostate specific genes and proteins
AU2002241557A1 (en) Compositions and methods relating to prostate specific genes and proteins